cocoon septal occluder&accessories , cocoon duct occluder & accessories
שילה חדשנות רפואית בע"מ - רופא - משתלים הנותנים פיתרונות למומים מולדים בלב
סולו מדרול 40 מג
pfizer pfe pharmaceuticals israel ltd - methylprednisolone as sodium succinate - אבקה להמסה להזרקה\אינפוזיה - methylprednisolone as sodium succinate 40 mg/vial - methylprednisolone - methylprednisolone - glucocorticosteroid with anti-inflammatory and anti allergic effect.
סולו קורטף 500
pfizer pfe pharmaceuticals israel ltd - hydrocortisone as sodium succinate - אבקה להמסה להזרקה\אינפוזיה - hydrocortisone as sodium succinate 500 mg/vial - hydrocortisone - hydrocortisone - glucocorticosteroid anti-inflammatory and anti-allergic
סולו-קורטף 100 מג
pfizer pfe pharmaceuticals israel ltd - hydrocortisone as sodium succinate - אבקה להמסה להזרקה\אינפוזיה - hydrocortisone as sodium succinate 100 mg - hydrocortisone - hydrocortisone - glucocorticosteroid, anti-inflammatory and anti-allergic .
פליקסוטייד משאף 50 מקג ללא cfc
glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף לשאיפה - fluticasone propionate 50 mcg/dose - fluticasone - glucocorticoids - prophylactic management of all grades of asthma. children aged 1 to 4 years: inhaled fluticasone propionate is of benefit to young children in the control of persistent asthma symptoms.
מקסיבון 10
unipharm ltd, israel - alendronic acid as sodium - טבליה - alendronic acid as sodium 10 mg - alendronic acid - alendronic acid - treatment of osteoporosis in postmenopausal women: maxibone is indicated for the treatment of osteoporosis to prevent fractures, including those of the hip, wrist and spine ( vertebral compression fractures). prevention and treatment of glucocorticoid-induced osteoporosis: maxibone is indicated for the prevention and treatment of glucocorticoid-induced osteoporosis in men and women. for the treatment of osteoporosis in men.
פורטאו
eli lilly israel ltd, israel - teriparatide - תמיסה להזרקה - teriparatide 250 mcg/ml - teriparatide - teriparatide - treatment of postmenopausal women with osteoporosis at high risk for fracture:forteo is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. in postmenopausal women with osteoporosis, forteo increases bmd reduces the risk of vertebral and nonvertebral fractures . increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture :forteo is indicated to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy . treatment of men and women with glucocorticoid-induced osteoporosis at high risk for fracture:forteo is indicated for the treatment of men and women with osteopo